Retinyl palmitate reduces hepatic fibrosis in rats induced by dimethylnitrosamine or pig serum

Journal of Hepatology

Volumn 29, Issue 6, 1998, Pages 933-943

  Mizobuchi, Yoko ^a   Shimizu, Ichiro ^a   Yasuda, Mitugi ^a   Hori, Hitoshi ^a   Shono, Masayuki ^a   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Antioxidant; Ito cells; Lipid peroxidation; Retinoid

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA ACTIN; COLLAGEN; DIMETHYLNITROSAMINE; IRON; MALONALDEHYDE; RETINOL PALMITATE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ITO CELL; LIPID PEROXIDATION; LIVER FIBROSIS; LIVER MITOCHONDRION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY BURST; SCAVENGING SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032404112     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80121-9     Document Type: Article

References (53)

1. 1. Goodman DS. Vitamin A metabolism in the liver. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, editors. The Liver: Biology and Pathobiology, 2nd ed. New York: Raven Press Ltd.; 1988. p. 467-74.
2. 2. Hendriks HFJ, Verhoofstad WAMM, Brouwer A, DeLeeuw AM, Knook DL. Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver. Exp Cell Res 1985; 160: 138-49.
3. 3. Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979; 76: 710-9.
4. 4. Seyer JM, Hutcheson ET, Kang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977; 59: 241-8.
5. 5. Grimaud JA, Druguet M, Peyrol S, Chevalier O, Herbage D, El Badrawy N. Collagen immunotyping in human liver: light and electron microscope study. J Histochem Cytochem 1980; 28: 1145-56.
6. 4-induced cirrhosis. Lab Invest 1985; 53: 166-86.
7. 7. Knook DL, Bosma A, Seifert WF. Role of vitamin A in liver fibrosis. J Gastroenterol Hepatol 1995; 10(Suppl 1): S47-9.
8. 8. Seifert WF, Bosma A, Hendriks HFJ, De Ruiter GCF, Van Leeuwen REW, Knook DL, et al. Dual role of vitamin A in experimental induced liver fibrosis. In: Decker K, Knook DL, Wisse E, editors. Cells of the Hepatic Sinusoid, Vol. 2. Leiden: The Kupffer Cell Foundation; 1989. p. 43-8.
9. 9. Seifert WF, Bosma A, Brouwer A, Hendriks HFJ, Roholl PJM, Van Leeuwen REW, et al. Vitamin A deficiency potentiates carbon tetrachloride-induced liver fibrosis in rats. Hepatology 1994; 19: 193-201.
10. 10. Sato T, Kato R, Tyson CA. Regulation of differentiated phenotype of rat hepatic lipocytes by retinoids in primary culture. Exp Cell Res 1995; 217: 72-83.
11. 11. Britton RS, Bacon BR. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 1994; 41: 343-8.
12. 12. Tsukamoto H, Rippe R, Niemela O, Lin M. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol 1995; 10(Suppl 1): S50-3.
13. 13. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 1993; 194: 1044-50.
14. 14. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGFα and collagen type IIs mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96: 2461-8.
15. 15. Shimizu I, Kamamura M, Yao D-F, Nii C, Horic T, Nishikado T, et al. Kallikrein-kinin system du. ring the cold presser test in cirrhotic rats. Int Hepatol Commun 1994; 2: 170-4.
16. 16. Shiba M, Shimizu I, Yasuda M, Ii K, Ito S. Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver 1998 (in press).
17. 17. Rubin E, Hutterer F, Popper H. Experimental hepatic fibrosis without hepatocellular regeneration: a kinetic study. Am J Pathol 1968; 52: 111-9.
18. 18. Senoo H, Wake K. Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab Invest 1985; 52: 182-94.
19. 19. Nanaev AK, Rukosuev VS, Shirinsky VP, Milovanov AP, Domogatsky SP, Duance VC, et al. Confocal and conventional immunofluorescent and immunogold electron microscopic localization of collagen types III and IV in human placenta. Placenta 1991; 12: 573-95.
20. 20. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103: 2787-96.
21. 21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 94: 403-8.
22. 22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
23. 23. Myers DK, Slater EC. Enzymatic hydrolysis of adenosine triphosphate by liver mitochondria I. Activities at different pH values. Biochem J 1957; 67: 558-72.
24. 24. Steinbrecht I, Augustin W. An improved modification of the biuret method for the determination of protein in turbid materials with high hemoglobin and lipid content. Biomed Biochim Acta 1983; 42: 335-42.
25. 25. Blois MS. Antioxidant determination by the use of a stable free radical. Nature 1958; 181: 1199-200.
26. 26. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 1989; 264: 10756-62.
27. 27. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometic studies of oxidative product formation by neutrophils: a graded response of membrane stimulation. J Immunol 1983; 130: 1910-7.
28. 28. Lyon BL, Schwarz RI. Ascorbate stimulation of PAT cells causes an increase in transcription rates and a decrease in degradation rates of procollagen mRNA. Nucleic Acids Res 1984; 12: 2569-79.
29. 29. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991; 13: 758-65.
30. 30. Houglum K, Brenner DA, Chojkier M. Inhibition of collagen gene expression by d-α-tocopherol in cultured human fibroblasts. J Clin Invest 1991; 87: 2230-5.
31. 31. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990; 86: 1991-8.
32. 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury. A link to tissue fibrosis? Hepatology 1994; 19: 1262-71.
33. 33. Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 1990; 10: 20-9.
34. 34. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990; 10: 30-46.
35. 35. Friedman SL, Roll FJ, Boyes J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic stellate cells by basement membrane matrix. J Biol Chem 1989; 264: 10756-62.
36. 36. Friedman SL, Arthur MJP. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. J Clin Invest 1989; 84: 1780-5.
37. 37. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effect of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 1786-93.
38. 38. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990; 11: 599-605.
39. 39. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatology 1992; 16: 776-84.
40. 2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation. Biochim Biophys Acta 1988; 961: 316-27.
41. 41. Bautista AP, Meszaros K, Bojta J, Spitzer JJ. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukoc Biol 1990; 48: 123-8.
42. 42. Redlich CA, Delisser HM, Elias JA. Retinoic acid inhibition of transforming growth factor-β-induced collagen production by human lung fibroblasts. Am J Respir Cell Mol Biol 1995; 12: 287-295.
43. 43. Hanazawa S, Takeshita A, Kitano S. Retinoic acid suppression of c-fos gene inhibits expression of tumor necrosis factor-α-induced monocyte chemoattractant JE/MCP-1 in clonal osteroblastic MC3T3-E1 cells. J Biol Chem 1994; 269: 21379-84.
44. 44. Russell RM, Boyer JL, Bagheri SA, Hruban Z. Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites. N Engl J Med 1974; 291: 435-40.
45. 45. Jacques EA, Buschmann RJ, Layden TJ. The histopathologic progression of vitamin A-induced hepatic injury. Gastroenterology 1979; 76: 599-602.
46. 46. Weber FL Jr, Mitchell GE Jr, Powell DE, Reiser BJ, Banwell JG. Reversible hepatotoxicity associated with hepatic vitamin A accumulation in a protein-deficient patient. Gastroenterology 1982; 82: 118-23.
47. 47. Hatoff DE, Gertler SL, Miyai K, Parker BA, Weiss JB. Hypervitaminosis A unmasked by acute viral hepatitis. Gastroenterology 1982; 82: 124-8.
48. 48. Leo MA, Lieber CS. Hepatic vitamin A deletion in alcoholic liver injury. N Engl J Med 1982; 307: 597-601.
49. 49. Hendriks HFJ, Bosma A, Brouwer A. Fat-storing cells: hyper- and hypovitaminosis A and the relationship with liver fibrosis. Semin Liver Dis 1993; 13: 72-80.
50. 50. Lippman SM, Benner SE, Hong WK. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res 1994; 54: 2025S-8S.
51. 51. Costa A, Formelli F, Chiesa F, Decensi A, De Palo G, Veronesi U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res 1994; 54: 2032S-7S.
52. 52. Moriwaki H, Muto Y, Ninomiya M, Kawai K, Suzuki Y, Seto T. Inhibitory effects of synthetic acidic retinoid and polyprenoic acid on the development of hepatoma in rats induced by 3′-methyl-N,N-dimethyl-4-aminoazobenzene. J Gastroenterol 1988; 23: 546-52.
53. 53. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334: 1561-7.